Latest News

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Cancer, pharmacology and therapeutics, Drug Development, Cancer Research, Prostate Cancer

Roswell Park Research Identifies Cells That May Be Responsible for Prostate Cancer Recurrence

205640XVP-4.jpg

A team from Roswell Park Cancer Institute has discovered a unique population of normal stem cells that may enable prostate cancer relapse. These findings may point the way toward strategies for treating or preventing prostate cancer recurrence.

Medicine

Channels:

Cancer, Cancer Research, Drug Development, Cancer Therapeutics, P53

Roswell Park Research Suggests New Strategy for Unleashing Cancer-Fighting Power of p53 Gene

ScreenShot2017-12-12at10.14.33AM.png

In a new study in the journal Nature Communications, a research team from Roswell Park Cancer Institute reports their discovery of a major mechanism by which cells regulate the tumor suppressor p53, opening up new avenues for cancer research and treatment.

Medicine

Channels:

Ash, American Society Of Hematology, Hematology, Cancer, Hematologic Cancers, Leukemia, Lymphoma, Cancer Research

Roswell Park Hematology Experts Sharing New Research in ASH 2017 Podium Presentations

eunice-wang-bio-headshot.jpg

Dr. Eunice Wang was invited to discuss results of a phase II clinical trial of crenolanib for adults with AML at the ASH 2017 annual meeting, and Dr. Kara Kelly, senior author of an oral abstract on outcomes disparities among children and adolescents with Hodgkin lymphoma.

Medicine

Channels:

Cancer, Immunotherapy, Immunology, Immune System, Side Effects, cancer guidelines

Society for Immunotherapy of Cancer Spearheads Initiative to Align Management of Immunotherapy Side Effects

igorpuzanov.jpg

The first consensus recommendations on recognition and clinical management of immune-related side effects from cancer immunotherapy are published today in the Journal for ImmunoTherapy of Cancer (JITC).

Medicine

Science

Channels:

Cancer, t cell therapy, adoptive cell therapy, Immunotherapy, Ovarian Cancer, Solid Tumor Cancers, Cancer Research, Clinical Trial, Cancer Treatments

‘Super T Cells’ Engineered for Optimal Performance Drive New Roswell Park Gene-Therapy Approach

Researchers at Roswell Park Cancer Institute have initiated a clinical trial based on a unique two-pronged strategy for arming the immune system to more effectively attack cancer cells.

Medicine

Channels:

Cancer, Melanoma, Carcinoma, Targeted Therapy, Cancer Research, Pharma

The Oncogene FOXQ1 Promotes Some Tumor Types, Suppresses Another

Nikiforov Cell Reports Figure 1A (2).jpg

In a new study published in Cell Reports, scientists report an unexpected finding — that the oncogene FOXQ1 suppresses the growth of melanoma cells.

Medicine

Channels:

Cancer, Cancer Research, Personalized Medicine, Precision Medicine, Cancer Therapeutics, ORIEN

Roswell Park Joins ORIEN Personalized Medicine Consortium

CMorrisonCJohnsonRPCICPM.jpg

Roswell Park Cancer has joined the Oncology Research Information Exchange Network, a unique research partnership among North America’s top cancer centers. Members of ORIEN contribute to a shared databank and collaborate on clinical research in order to develop new and better treatment options for cancer patients.

Medicine

Channels:

Cancer, Side Effects, cancer treatment side effects, Neuropathy, Vitamins, Nutrition, Vitamin Supplements, Multivitamins, Cancer Prevention, Epidemiology, Breast Cancer

Multivitamins May Reduce Incidence of Neuropathy from Chemotherapy

ChristineAmbrosone.jpg

A new study from Roswell Park Cancer Institute reports that women with breast cancer who took multivitamin supplements were less likely to develop chemotherapy-induced neuropathy.

Medicine

Science

Channels:

Cancer, Cancer Research, Fluorescence, Fluorescent Protein Imaging, Cancer Therapeutics

Team Develops Fluorescent Sensors That May Pave Way for New Cancer Therapies

GTPsensorimage2.jpg

New research led by a team from Roswell Park Cancer Institute and published in the journal Nature Methods reports the development of the first tool for detecting changes in GTP levels in living cells.

Medicine

Channels:

Cancer, Beta Blockers, Cancer Research, Immunotherapy, checkpoint inhibitors, Checkpoint Inhibition

Beta Blockers May Hold Key to Unleashing Potential of Checkpoint Inhibitors, Roswell Park Team Shows

BetsyRepaskyinOffice2011-10-038-lowres.jpg

In new research published in the journal Cancer Research, a team from Roswell Park has shown that "beta blocker" drugs appear to be an effective means of reducing beta-2 receptor signaling and, in the process, may improve the efficacy of checkpoint inhibitor immunotherapy







Chat now!